Its better to walk alone than with the crowd going in the wrong direction
Medicare for All would save the American people $2 trillion over a 10-year period. … according to the Mercatus Center.
It assumes that provider payment will be reduced to Medicare levels, that negotiation with prescription drugmakers will generate significant savings, and that administrative costs will be cut from 13 to 6 percent.
The pharma industry continues to be the target of politicians and the media.
Pharma’s CEO’s primary customer is Wall Street, not patients.
Trade magazines are not discussing the key challenges facing our industry, rather they cater to pharma with awards that that wind up being just a bullet point on resumes.
Before the industry can change they need to hire more “pirates” and break the pharma ecosystem that recycles people from one company to another.
Pharma and agencies love to be recognized by industry trade magazines.
The awards themselves are virtually worthless.
These awards lead to cross hiring within pharma and look on a resume, nothing else.
The best recognition comes from patients who say “thank you” for helping them overcome illness.
The pharma industry cannot continue “business as usual”.
Patients have too many treatment options and feel pharma “is the enemy”.
The industry continues to ignore the most serious patients in need.
DTC tries too hard to sell.
Eisai and Biogen posted promising data for BAN2401 that lifted its stock and had the pharma trade publications talking breakthrough.
But there is a lot of controversy swirling around the study.
It seems that Biogen may have moved the goal posts to gain more favorable data endpoints.
It’s not about patients, it’s about the stock price and getting investors on board.
Several pharmaceutical companies have recently said they’ll delay some of their price increases, under pressure from the Trump administration. But hospitals have made no such concessions, even though they make up a much larger share of total health care spending.
Pfizer, Novartis, Merck and other drug makers have said they will delay, freeze or roll back price increases on some of their medicines. Experts largely dismissed those pledges as political bandages with little real effect on patients’ pocketbooks.
Drug pricing is the political controversy of the moment, but hospitals cost the health care system far more.
Only 3% of healthcare advertising is spent on digital.
Pharma websites are not designed to engage users they are there to strictly inform people about the advertised drug.
An estimated $7.4 billion (£5.5 billion) was wasted on display ads alone in 2016, a figure that will rise to $10.9 billion (£8 billion) by 2021, according to Forrester.
Before serving an ad, marketers must gain insight on target audiences. Many take a “spray and pray” approach, hoping to drive performance success.
with 52% estimating that 10-50% of their marketing spend is lost to fraud.
, while under even the best-case scenario, one-third of those impressions aren’t viewed by an actual person.